Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meagan C Fitzpatrick

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
The Journal of Allergy and Clinical Immunology. Global|May 22, 2023
Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalenceJustin R Ortiz, Rachel S Laufer, Steven M Brunwasser, et al.
Vaccine|September 30, 2023
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022Meagan C Fitzpatrick, Rachel S Laufer, Ranju Baral, et al.
PLOS Global Public Health|November 15, 2023
Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger: A cluster-randomized trialAhmed M Arzika, Ramatou Maliki, Abdou Amza, et al.
BMJ Open|August 30, 2023
Antenatal, intrapartum and infant azithromycin to prevent stillbirths and infant deaths: study protocol for SANTE, a 2×2 factorial randomised controlled trial in MaliAmanda J Driscoll, Fadima Cheick Haidara, Milagritos D Tapia, et al.
The American Journal of Tropical Medicine and Hygiene|April 8, 2025
Costs, Coverage, and Acceptability of Azithromycin Mass Administration to Children 1-11 Versus 1-59 Months Old to Reduce Mortality: A Cluster-Randomized Trial in NigerAhmed M Arzika, Ramatou Maliki, Abdou Amza, et al.
PLOS Global Public Health|June 26, 2026
Micro-costing for national-scale azithromycin mass drug administration to improve child survival in NigerBrittany Peterson, William Nguyen, Laminou Maliki Haroun, et al.
Vaccine|July 30, 2021
Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisionsRachel S Laufer, Amanda J Driscoll, Ranju Baral, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
The Journal of Allergy and Clinical Immunology. Global|May 22, 2023
Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalenceJustin R Ortiz, Rachel S Laufer, Steven M Brunwasser, et al.
Vaccine|September 30, 2023
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022Meagan C Fitzpatrick, Rachel S Laufer, Ranju Baral, et al.
PLOS Global Public Health|November 15, 2023
Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger: A cluster-randomized trialAhmed M Arzika, Ramatou Maliki, Abdou Amza, et al.
BMJ Open|August 30, 2023
Antenatal, intrapartum and infant azithromycin to prevent stillbirths and infant deaths: study protocol for SANTE, a 2×2 factorial randomised controlled trial in MaliAmanda J Driscoll, Fadima Cheick Haidara, Milagritos D Tapia, et al.
The American Journal of Tropical Medicine and Hygiene|April 8, 2025
Costs, Coverage, and Acceptability of Azithromycin Mass Administration to Children 1-11 Versus 1-59 Months Old to Reduce Mortality: A Cluster-Randomized Trial in NigerAhmed M Arzika, Ramatou Maliki, Abdou Amza, et al.
PLOS Global Public Health|June 26, 2026
Micro-costing for national-scale azithromycin mass drug administration to improve child survival in NigerBrittany Peterson, William Nguyen, Laminou Maliki Haroun, et al.
Vaccine|July 30, 2021
Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisionsRachel S Laufer, Amanda J Driscoll, Ranju Baral, et al.
Pageof 9